Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04450277 Completed - COVID-19 Clinical Trials

Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

Emergency general surgical care during the COVID-19 pandemic presents a unique set of considerations and challenges. Patients presenting with acute surgical conditions and concomitant COVID-19 infection have higher risk of mortality and morbidity. The investigators present their experience with COVID-19 positive patients presenting with acute surgical conditions and reviewed the implementation of a protocolized pathway to mitigate the impact of COVID-19 infection.

NCT ID: NCT04449731 Completed - COVID-19 Clinical Trials

Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int)

COVIDiet_Int
Start date: March 20, 2020
Phase:
Study type: Observational

This cross-sectional study will allow to collect eating behaviours data during the COVID-19 confinement, some of them related to the Mediterranean Diet to better understand the eating behaviours of adult population during this novel and exceptional situation. Hypothesis: The eating habits of the population together with physical activity level will change during the COVID-19 outbreak confinement.

NCT ID: NCT04449718 Completed - COVID-19 Clinical Trials

Vitamin D Supplementation in Patients With COVID-19

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Coronavirus disease 2019 (COVID-19) was declared an emergency public health problem by the World Health Organization (WHO) in March 2020. Since then, several initiatives by the medical and scientific community have sought alternatives to treat infected individuals, as well as identifying risk or protective factors for the contamination and prognosis of patients. In this perspective, vitamin D supplementation can improve some important outcomes in critically ill patients, being considered a potent immunomodulatory agent. Vitamin D deficiency is a common outcome in critically ill patients, thus making it a modifiable risk factor with great potential for reducing hospital stay and intensive care and mortality. The investigators speculate that vitamin D supplementation could have therapeutic effects in patients with COVID-19.

NCT ID: NCT04449276 Completed - COVID-19 Clinical Trials

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Start date: June 18, 2020
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the safety and reactogenicity profile after 1 and 2 dose administrations of CVnCoV at different dose levels.

NCT ID: NCT04449094 Completed - COVID Clinical Trials

Emergence of the COVID 19 Epidemic in the City of Nice

Start date: February 28, 2020
Phase:
Study type: Observational

Descriptive analysis of the appearance of the first cases of COVID 19 diagnosed in the city of Nice. Analysis of the association of socio-demographic factors with the viremia attack rate according to the district of residence.

NCT ID: NCT04449042 Completed - COVID19 Clinical Trials

The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

The COVID-19 pandemic has disrupted anesthesia care all over the world. There remains very little data on current practice patterns and patient outcomes, particularly in anesthetized children. This is a prospective observational, multi-center study to investigate airway management related outcomes in children undergoing anesthesia during this pandemic. The investigators will compare the incidence of complications (particularly hypoxemia) in patients with COVID-19 to those who are COVID-19 negative during airway management. PAWS COVID-19 Registry https://is.gd/PEDICOVID19 Registration link https://is.gd/researchrequest

NCT ID: NCT04448756 Completed - Clinical trials for Coronavirus Disease 2019

Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)

Start date: July 29, 2020
Phase: Phase 2
Study type: Interventional

The study will evaluate the safety and efficacy of orally-administered M5049 in Coronavirus disease 2019 (COVID-19) pneumonia participants who are hospitalized but not on mechanical ventilation.

NCT ID: NCT04448743 Completed - COVID-19 Clinical Trials

Role of Microparticles in Covid-19 Infection

MICO
Start date: July 2, 2020
Phase:
Study type: Observational

Among the distinctive features of Covid-19, numerous reports have stressed the importance of vascular damages associated with coagulopathy onset. Microparticles (MPs) shed by apoptotic/stimulated cells are reliable markers of vascular damage released upon pro-inflammatory conditions and behave as active participants in the early steps of clot formation. In addition, MPs carry ACE1 and ACE2, the cell-entry receptor for SARS-Cov2 in the vasculature and up-regulate ACE1 expression in neighbouring endothelial cells. This may contribute to unopposed angiotensin II accumulation which further exacerbate tissue injury and promote both inflammation and thrombosis. The aim of the study is to evaluate the impact of circulating MPs on ACE2 expression, the cell-entry receptor for SARS-Cov2 on endothelial cells.

NCT ID: NCT04448418 Completed - COVID-19 Clinical Trials

The Impact of COVID-19 Outbreak on Trans-population's Health in Italy

Start date: May 20, 2020
Phase:
Study type: Observational

During the COVID-19 outbreak, it was necessary to remodel the healthcare offer for all categories of subjects in order to minimize unnecessary movements of people while maintaining an adequate level of assistance. This is also true for transgender people, who are periodically requested to come into the clinic for hormonal therapy monitoring and continuation. In our center telemedicine programs dedicated to users have been activated for the remote management of hormone therapy. We use a web-based survey to assess the impact of COVID-19 outbreak on trans-population health and to assess the specific needs of this population in this particular moment.

NCT ID: NCT04447534 Completed - COVID Clinical Trials

Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

Start date: June 23, 2020
Phase: Phase 3
Study type: Interventional

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.